Monitoring vaccine temperatures throughout the supply chain is of utmost importance to preserve their quality and potency.
In South Korea, nearly 5 million seasonal flu vaccines reserved for children were exposed to suboptimal temperatures during distribution. This revelation sparked public concerns regarding the safety and efficacy of these vaccines.
In response, the government mandated a stricter cold chain monitoring process and reporting. But at the time, pharma manufacturers remained restricted in their ability to access temperature reports beyond the point of origin, leaving them unable to track their products once they leave the plant.